Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn Guymer

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Survey of Ophthalmology|October 9, 2017
Restorative retinal laser therapy: Present state and future directionsJay Chhablani, Young Jung Roh, Andrew I Jobling, et al.
Ophthalmology|October 2, 2012
The SECURE study: long-term safety of ranibizumab 0.5 mg in neovascular age-related macular degenerationRufino Silva, Ruth Axer-Siegel, Bora Eldem, et al.
Acta Ophthalmologica|July 13, 2013
Effect of simvastatin on retinal vascular caliber: the Age-Related Maculopathy Statin StudyMariko Sasaki, Wei Lin Gan, Ryo Kawasaki, et al.
Ophthalmology|September 5, 2013
Author reply: To PMID 23021093Rufino Silva, Ruth Axer-Siegel, Bora Eldem, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 11, 2024
RWC Update: Removal of Subretinal Band Without Retinotomy; Geographic Atrophy: How Do You Select Appropriate Patients for Anti-Complement Therapy?; Shaken Baby SyndromeAshish Sharma, Lihteh Wu, Steven Bloom, et al.
Investigative Ophthalmology & Visual Science|January 20, 2011
Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMDSanjeewa S Wickremasinghe, Jing Xie, Jonathan Lim, et al.
BMC Ophthalmology|December 24, 2008
Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM StudyCatherine A McCarty, Adam Dowrick, James Cameron, et al.
Ophthalmology|December 15, 2010
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE studyUrsula Schmidt-Erfurth, Bora Eldem, Robyn Guymer, et al.
Ophthalmology|December 1, 2024
Anatomic Outcomes with Faricimab vs Aflibercept in Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular Age-related Macular DegenerationChui Ming Gemmy Cheung, Jennifer I Lim, Siegfried Priglinger, et al.
The British Journal of Ophthalmology|December 23, 2022
Hyperpigmentary abnormalities in age-related macular degeneration: association with progression and impact on visual sensitivityKai Lyn Goh, Himeesh Kumar, Xavier Hadoux, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Survey of Ophthalmology|October 9, 2017
Restorative retinal laser therapy: Present state and future directionsJay Chhablani, Young Jung Roh, Andrew I Jobling, et al.
Ophthalmology|October 2, 2012
The SECURE study: long-term safety of ranibizumab 0.5 mg in neovascular age-related macular degenerationRufino Silva, Ruth Axer-Siegel, Bora Eldem, et al.
Acta Ophthalmologica|July 13, 2013
Effect of simvastatin on retinal vascular caliber: the Age-Related Maculopathy Statin StudyMariko Sasaki, Wei Lin Gan, Ryo Kawasaki, et al.
Ophthalmology|September 5, 2013
Author reply: To PMID 23021093Rufino Silva, Ruth Axer-Siegel, Bora Eldem, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|June 11, 2024
RWC Update: Removal of Subretinal Band Without Retinotomy; Geographic Atrophy: How Do You Select Appropriate Patients for Anti-Complement Therapy?; Shaken Baby SyndromeAshish Sharma, Lihteh Wu, Steven Bloom, et al.
Investigative Ophthalmology & Visual Science|January 20, 2011
Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMDSanjeewa S Wickremasinghe, Jing Xie, Jonathan Lim, et al.
BMC Ophthalmology|December 24, 2008
Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: the CHARM StudyCatherine A McCarty, Adam Dowrick, James Cameron, et al.
Ophthalmology|December 15, 2010
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE studyUrsula Schmidt-Erfurth, Bora Eldem, Robyn Guymer, et al.
Ophthalmology|December 1, 2024
Anatomic Outcomes with Faricimab vs Aflibercept in Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular Age-related Macular DegenerationChui Ming Gemmy Cheung, Jennifer I Lim, Siegfried Priglinger, et al.
The British Journal of Ophthalmology|December 23, 2022
Hyperpigmentary abnormalities in age-related macular degeneration: association with progression and impact on visual sensitivityKai Lyn Goh, Himeesh Kumar, Xavier Hadoux, et al.
Pageof 9